Survival outcomes of marijuana users in p16 positive oropharynx cancer patients.
Han ZhangMichael XieMarc LevinStuart D ArchibaldB Stanley JacksonJ E M YoungMichael K GuptaPublished in: Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale (2019)
No survival difference is found between HPV-related OPSCC marijuana users and non-users. This finding has implications for both de-escalation regimes and the use of cannabis as a therapeutic agent.